COX-2 gene expression and immunoreactivity were examined in clinical specimens with documented mutations, as well as in spheroids and allografts derived from mouse pheochromocytoma (MPC) cells. The gene discussed is PTGS2; the disease is hereditary pheochromocytoma-paraganglioma.